TI17

TI17 is an inhibitor of Thyroid Hormone Receptor used in studies of DNA Damage Response and Apoptosis and related signaling programs. In practice, this places the compound in experiments that measure checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and cell cycle models.

By inhibiting Thyroid Hormone Receptor, TI17 can be used to examine checkpoint activation, DNA repair, and genome-stability control and caspase-associated cell-death signaling and survival decisions. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Thyroid Hormone Receptor
• Pathway perturbation studies connected to DNA Damage Response and Apoptosis and related signaling programs
• Concentration-response inhibition and target-dependence studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, TI17 is appropriate when a defined chemical perturbant is needed to connect Thyroid Hormone Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.